Cure HHT Email Format
Research ServicesMaryland, United States11-50 Employees
Cure HHT is a patient advocacy organization focused on hereditary hemorrhagic telangiectasia (HHT). It operates in the research-services space by funding and coordinating initiatives that aim to improve therapies, expand access to care, build a patient registry, and standardize treatment for people living with HHT. The organization serves a global community of more than 1.4 million individuals and seeks to advance care today and for future generations. Based in Monkton, Maryland, Cure HHT functions as a nonprofit entity that connects patients, researchers, and clinicians to advance understanding and management of HHT. In recent activity, its registry research was selected for oral presentation at the American Society of Hematology 2025 Annual Meeting, reflecting ongoing collaboration with the broader hematology community.